Ligand validation:3MF2

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3MF2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3MF2_AMP_A_1010	91%	30%	0.066	0.95	1.59	1.19	3	3	0	0	100%	1
3MF2_AMP_B_1010	59%	25%	0.102	0.881	1.58	1.48	4	5	1	0	100%	1
4H2V_AMP_A_402	89%	59%	0.1	0.978	0.71	0.87	-	1	0	0	100%	1
4H2S_AMP_A_1001	78%	61%	0.121	0.965	0.64	0.86	-	1	1	0	100%	0.84
4H2W_AMP_B_402	71%	60%	0.123	0.945	0.66	0.86	-	1	2	0	100%	0.82
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.